Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
26
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Scott Kathleen D. | Director | 1 | $0 | $0 | 2019-11-18 |
| Marshall Keith W | EVP, COO & CFO | 7 | $0 | $0 | 2019-08-01 |
| VANDERTIE MICHELLE L | Vice President, Finance | 12 | $0 | $0 | 2019-08-01 |
| Spada Alfred P. | SVP, R&D and CSO | 19 | $0 | $0 | 2019-08-01 |
| Mento Steven J | President, CEO & Director | 27 | $151.8K | $0 | 2019-08-01 |
| Van Wart Harold | Director | 9 | $0 | $0 | 2019-06-27 |
| Klassen Preston | Director | 6 | $0 | $0 | 2019-06-27 |
| LARUE WILLIAM R | Director | 3 | $0 | $0 | 2019-06-27 |
| KISNER DANIEL L | Director | 10 | $23.0K | $0 | 2019-06-27 |
| HALE DAVID F | Director | 15 | $28.5K | $0 | 2019-06-27 |
| RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | 7 | $0 | $0 | 2019-02-07 |
| Smith Edward F III | SVP, Reg Affairs and QA | 7 | $0 | $0 | 2019-02-07 |
| Hagerty David T | EVP, Clinical Development | 6 | $0 | $0 | 2019-02-07 |
| Scopa James Paul | Director | 12 | $1.82M | $0 | 2018-06-21 |
| Cashion Charles | SVP, Finance, CFO and Sec. | 9 | $0 | $0 | 2017-01-26 |
| Malik Shahzad | Director, 10% Owner | 12 | $2.09M | $5.9K | 2016-06-23 |
| LACASSE LOUIS P | Director | 7 | $1.36M | $0 | 2015-06-11 |
| KLINGENSTEIN PAUL H | Director, 10% Owner | 33 | $1.18M | $6.2K | 2014-02-19 |
| Aberdare Partners III LP | Other | 4 | $0 | $0 | 2014-02-19 |
| BURGESS GARY C. | Sr. VP, Clin. Res. & CMO | 1 | $0 | $0 | 2014-02-07 |
| COOPERATIVE GILDE HEALTHCARE II U.A. | 10% Owner | 8 | $1.82M | $3.9K | 2013-07-30 |
| Foley Todd | 10% Owner | 6 | $1.82M | $0 | 2013-07-30 |
| Perret Marc Olivier | Director, 10% Owner | 9 | $1.82M | $3.9K | 2013-07-30 |
| MPM BioVentures IV LLC | 10% Owner | 6 | $1.82M | $0 | 2013-07-30 |
| Aberdare Ventures III LP | 10% Owner | 26 | $1.18M | $6.2K | 2013-07-30 |
| ADVENT VENTURE PARTNERS LLP | 10% Owner | 8 | $2.09M | $5.9K | 2013-07-30 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Scott Kathleen D. | Director | A Award deriv | 2019-11-18 | 2019-11-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Mento Steven J | President, CEO & Director | D To issuer deriv | 2019-08-01 | 2019-08-01 | 150,000 | — | $0 | 0 | SEC↗ |
| Mento Steven J | President, CEO & Director | D To issuer deriv | 2019-08-01 | 2019-08-01 | 400,000 | — | $0 | 0 | SEC↗ |
| Mento Steven J | President, CEO & Director | A Award deriv | 2019-08-01 | 2019-08-01 | 650,000 | — | $0 | 650,000 | SEC↗ |
| Mento Steven J | President, CEO & Director | D To issuer deriv | 2019-08-01 | 2019-08-01 | 350,000 | — | $0 | 0 | SEC↗ |
| Mento Steven J | President, CEO & Director | D To issuer deriv | 2019-08-01 | 2019-08-01 | 50,000 | — | $0 | 0 | SEC↗ |
| Mento Steven J | President, CEO & Director | D To issuer deriv | 2019-08-01 | 2019-08-01 | 172,500 | — | $0 | 0 | SEC↗ |
| Mento Steven J | President, CEO & Director | D To issuer deriv | 2019-08-01 | 2019-08-01 | 37,500 | — | $0 | 0 | SEC↗ |
| Mento Steven J | President, CEO & Director | D To issuer deriv | 2019-08-01 | 2019-08-01 | 20,000 | — | $0 | 0 | SEC↗ |
| Mento Steven J | President, CEO & Director | D To issuer deriv | 2019-08-01 | 2019-08-01 | 120,000 | — | $0 | 0 | SEC↗ |
| Marshall Keith W | EVP, COO & CFO | D To issuer deriv | 2019-08-01 | 2019-08-01 | 525,000 | — | $0 | 0 | SEC↗ |
| Marshall Keith W | EVP, COO & CFO | D To issuer deriv | 2019-08-01 | 2019-08-01 | 70,000 | — | $0 | 0 | SEC↗ |
| Marshall Keith W | EVP, COO & CFO | D To issuer deriv | 2019-08-01 | 2019-08-01 | 175,000 | — | $0 | 0 | SEC↗ |
| Marshall Keith W | EVP, COO & CFO | A Award deriv | 2019-08-01 | 2019-08-01 | 385,000 | — | $0 | 385,000 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | D To issuer deriv | 2019-08-01 | 2019-08-01 | 100,000 | — | $0 | 0 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | D To issuer deriv | 2019-08-01 | 2019-08-01 | 50,000 | — | $0 | 0 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | D To issuer deriv | 2019-08-01 | 2019-08-01 | 109,375 | — | $0 | 0 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | D To issuer deriv | 2019-08-01 | 2019-08-01 | 21,875 | — | $0 | 0 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | D To issuer deriv | 2019-08-01 | 2019-08-01 | 100,625 | — | $0 | 0 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | D To issuer deriv | 2019-08-01 | 2019-08-01 | 70,000 | — | $0 | 0 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | D To issuer deriv | 2019-08-01 | 2019-08-01 | 175,000 | — | $0 | 0 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | A Award deriv | 2019-08-01 | 2019-08-01 | 313,436 | — | $0 | 313,436 | SEC↗ |
| VANDERTIE MICHELLE L | Vice President, Finance | D To issuer deriv | 2019-08-01 | 2019-08-01 | 20,000 | — | $0 | 0 | SEC↗ |
| VANDERTIE MICHELLE L | Vice President, Finance | A Award deriv | 2019-08-01 | 2019-08-01 | 86,375 | — | $0 | 86,375 | SEC↗ |
| VANDERTIE MICHELLE L | Vice President, Finance | D To issuer deriv | 2019-08-01 | 2019-08-01 | 15,000 | — | $0 | 0 | SEC↗ |
| VANDERTIE MICHELLE L | Vice President, Finance | D To issuer deriv | 2019-08-01 | 2019-08-01 | 15,000 | — | $0 | 0 | SEC↗ |
| VANDERTIE MICHELLE L | Vice President, Finance | D To issuer deriv | 2019-08-01 | 2019-08-01 | 50,000 | — | $0 | 0 | SEC↗ |
| VANDERTIE MICHELLE L | Vice President, Finance | D To issuer deriv | 2019-08-01 | 2019-08-01 | 16,000 | — | $0 | 0 | SEC↗ |
| VANDERTIE MICHELLE L | Vice President, Finance | D To issuer deriv | 2019-08-01 | 2019-08-01 | 23,000 | — | $0 | 0 | SEC↗ |
| VANDERTIE MICHELLE L | Vice President, Finance | D To issuer deriv | 2019-08-01 | 2019-08-01 | 3,750 | — | $0 | 0 | SEC↗ |
| VANDERTIE MICHELLE L | Vice President, Finance | D To issuer deriv | 2019-08-01 | 2019-08-01 | 15,000 | — | $0 | 0 | SEC↗ |
| VANDERTIE MICHELLE L | Vice President, Finance | D To issuer deriv | 2019-08-01 | 2019-08-01 | 15,000 | — | $0 | 0 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2019-06-27 | 2019-07-01 | 45,000 | — | $0 | 45,000 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2019-06-27 | 2019-07-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Klassen Preston | Director | A Award deriv | 2019-06-27 | 2019-07-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LARUE WILLIAM R | Director | A Award deriv | 2019-06-27 | 2019-07-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Van Wart Harold | Director | A Award deriv | 2019-06-27 | 2019-07-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Mento Steven J | President, CEO & Director | A Award deriv | 2019-02-07 | 2019-02-11 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Hagerty David T | EVP, Clinical Development | A Award deriv | 2019-02-07 | 2019-02-11 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Marshall Keith W | EVP, COO & CFO | A Award deriv | 2019-02-07 | 2019-02-11 | 175,000 | — | $0 | 175,000 | SEC↗ |
| RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | A Award deriv | 2019-02-07 | 2019-02-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Smith Edward F III | SVP, Reg Affairs and QA | A Award deriv | 2019-02-07 | 2019-02-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | A Award deriv | 2019-02-07 | 2019-02-11 | 175,000 | — | $0 | 175,000 | SEC↗ |
| VANDERTIE MICHELLE L | Vice President, Finance | A Award deriv | 2019-02-07 | 2019-02-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | A Award | 2018-11-14 | 2019-02-11 | 1,861 | $3.15 | $5.9K | 32,431 | SEC↗ |
| Smith Edward F III | SVP, Reg Affairs and QA | A Award | 2018-11-14 | 2019-02-11 | 1,724 | $3.15 | $5.4K | 10,875 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Klassen Preston | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LARUE WILLIAM R | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Scopa James Paul | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Van Wart Harold | Director | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | A Award | 2018-05-14 | 2019-02-11 | 1,290 | $3.31 | $4.3K | 30,570 | SEC↗ |
| Smith Edward F III | SVP, Reg Affairs and QA | A Award | 2018-05-14 | 2019-02-11 | 4,690 | $3.31 | $15.5K | 9,151 | SEC↗ |
| Mento Steven J | President, CEO & Director | M Exercise deriv | 2018-05-04 | 2018-05-07 | 60,000 | — | $0 | 147,070 | SEC↗ |
| Mento Steven J | President, CEO & Director | M Exercise | 2018-05-04 | 2018-05-07 | 60,000 | $0.99 | $59.4K | 60,000 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | M Exercise deriv | 2018-02-27 | 2018-03-01 | 12,121 | — | $0 | 0 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | M Exercise | 2018-02-27 | 2018-03-01 | 12,121 | $1.24 | $15.0K | 12,121 | SEC↗ |
| Mento Steven J | President, CEO & Director | A Award deriv | 2018-02-04 | 2018-02-05 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Hagerty David T | EVP, Clinical Development | A Award deriv | 2018-02-04 | 2018-02-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Marshall Keith W | EVP, COO & CFO | A Award deriv | 2018-02-04 | 2018-02-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | A Award deriv | 2018-02-04 | 2018-02-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Smith Edward F III | SVP, Reg Affairs and QA | A Award deriv | 2018-02-04 | 2018-02-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | A Award deriv | 2018-02-04 | 2018-02-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| VANDERTIE MICHELLE L | Vice President, Finance | A Award deriv | 2018-02-04 | 2018-02-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | A Award | 2017-11-14 | 2018-02-05 | 818 | $3.48 | $2.8K | 29,280 | SEC↗ |
| Smith Edward F III | SVP, Reg Affairs and QA | A Award | 2017-11-14 | 2018-02-05 | 4,461 | $3.48 | $15.5K | 4,461 | SEC↗ |
| Marshall Keith W | EVP, COO & CFO | A Award deriv | 2017-08-31 | 2017-09-01 | 525,000 | — | $0 | 525,000 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2017-06-22 | 2017-06-26 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Van Wart Harold | Director | A Award deriv | 2017-06-22 | 2017-06-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2017-06-22 | 2017-06-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Klassen Preston | Director | A Award deriv | 2017-06-22 | 2017-06-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Scopa James Paul | Director | A Award deriv | 2017-06-22 | 2017-06-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | A Award | 2017-05-12 | 2018-02-05 | 761 | $1.70 | $1.3K | 28,462 | SEC↗ |
| LARUE WILLIAM R | Director | A Award deriv | 2017-02-06 | 2017-02-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Mento Steven J | President, CEO & Director | A Award deriv | 2017-01-26 | 2017-02-01 | 172,500 | — | $0 | 172,500 | SEC↗ |
| Cashion Charles | SVP, Finance, CFO and Sec. | A Award deriv | 2017-01-26 | 2017-02-01 | 57,500 | — | $0 | 57,500 | SEC↗ |
| Hagerty David T | EVP, Clinical Development | A Award deriv | 2017-01-26 | 2017-02-01 | 100,625 | — | $0 | 100,625 | SEC↗ |
| Smith Edward F III | SVP, Reg Affairs and QA | A Award deriv | 2017-01-26 | 2017-02-01 | 57,500 | — | $0 | 57,500 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | A Award deriv | 2017-01-26 | 2017-02-01 | 100,625 | — | $0 | 100,625 | SEC↗ |
| RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | A Award deriv | 2017-01-26 | 2017-02-02 | 73,000 | — | $0 | 73,000 | SEC↗ |
| Cashion Charles | SVP, Finance, CFO and Sec. | M Exercise deriv | 2017-01-09 | 2017-01-11 | 42,424 | — | $0 | 0 | SEC↗ |
| Cashion Charles | SVP, Finance, CFO and Sec. | M Exercise | 2017-01-09 | 2017-01-11 | 42,424 | $0.99 | $42.0K | 42,424 | SEC↗ |
| KISNER DANIEL L | Director | J Other | 2016-12-28 | 2016-12-30 | 2,310 | — | $0 | 5,455 | SEC↗ |
| Mento Steven J | President, CEO & Director | M Exercise deriv | 2016-12-20 | 2016-12-22 | 36,363 | — | $0 | 0 | SEC↗ |
| Mento Steven J | President, CEO & Director | M Exercise deriv | 2016-12-20 | 2016-12-22 | 5,051 | — | $0 | 207,070 | SEC↗ |
| Mento Steven J | President, CEO & Director | M Exercise | 2016-12-20 | 2016-12-22 | 5,051 | $0.99 | $5.0K | 41,414 | SEC↗ |
| Mento Steven J | President, CEO & Director | M Exercise | 2016-12-20 | 2016-12-22 | 36,363 | $1.24 | $45.1K | 36,363 | SEC↗ |
| Van Wart Harold | Director | M Exercise deriv | 2016-10-27 | 2016-10-31 | 18,181 | — | $0 | 0 | SEC↗ |
| Van Wart Harold | Director | M Exercise | 2016-10-27 | 2016-10-31 | 18,181 | $0.25 | $4.5K | 18,181 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2016-06-23 | 2016-06-24 | 45,000 | — | $0 | 45,000 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2016-06-23 | 2016-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Klassen Preston | Director | A Award deriv | 2016-06-23 | 2016-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Scopa James Paul | Director | A Award deriv | 2016-06-23 | 2016-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Van Wart Harold | Director | A Award deriv | 2016-06-23 | 2016-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Malik Shahzad | Director, 10% Owner | A Award deriv | 2016-06-23 | 2016-06-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Smith Edward F III | SVP, Reg Affairs and QA | A Award deriv | 2016-04-01 | 2016-04-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Mento Steven J | President, CEO & Director | A Award deriv | 2016-02-04 | 2016-02-08 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Mento Steven J | President, CEO & Director | A Award deriv | 2016-02-04 | 2016-02-08 | 187,500 | — | $0 | 187,500 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | A Award deriv | 2016-02-04 | 2016-02-08 | 21,875 | — | $0 | 21,875 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | A Award deriv | 2016-02-04 | 2016-02-08 | 109,375 | — | $0 | 109,375 | SEC↗ |
| Hagerty David T | EVP, Clinical Development | A Award deriv | 2016-02-04 | 2016-02-08 | 109,375 | — | $0 | 109,375 | SEC↗ |
| Hagerty David T | EVP, Clinical Development | A Award deriv | 2016-02-04 | 2016-02-08 | 21,875 | — | $0 | 21,875 | SEC↗ |
| Cashion Charles | SVP, Finance, CFO and Sec. | A Award deriv | 2016-02-04 | 2016-02-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Cashion Charles | SVP, Finance, CFO and Sec. | A Award deriv | 2016-02-04 | 2016-02-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2015-06-11 | 2015-06-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2015-06-11 | 2015-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Klassen Preston | Director | A Award deriv | 2015-06-11 | 2015-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LACASSE LOUIS P | Director | A Award deriv | 2015-06-11 | 2015-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Malik Shahzad | Director, 10% Owner | A Award deriv | 2015-06-11 | 2015-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Scopa James Paul | Director | A Award deriv | 2015-06-11 | 2015-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Van Wart Harold | Director | A Award deriv | 2015-06-11 | 2015-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KISNER DANIEL L | Director | P Buy | 2015-04-08 | 2015-04-10 | 4,000 | $5.75 | $23.0K | 7,145 | SEC↗ |
| Mento Steven J | President, CEO & Director | A Award deriv | 2015-02-23 | 2015-02-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Mento Steven J | President, CEO & Director | A Award deriv | 2015-02-23 | 2015-02-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Spada Alfred P. | EVP, R&D and CSO | A Award deriv | 2015-02-23 | 2015-02-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Cashion Charles | SVP, Finance, CFO and Sec. | A Award deriv | 2015-02-23 | 2015-02-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Hagerty David T | EVP, Clinical Development | A Award deriv | 2014-10-01 | 2014-10-03 | 175,000 | — | $0 | 175,000 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2014-06-19 | 2014-06-23 | 35,000 | — | $0 | 35,000 | SEC↗ |
| LACASSE LOUIS P | Director | A Award deriv | 2014-06-19 | 2014-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Malik Shahzad | Director, 10% Owner | A Award deriv | 2014-06-19 | 2014-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Scopa James Paul | Director | A Award deriv | 2014-06-19 | 2014-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Van Wart Harold | Director | A Award deriv | 2014-06-19 | 2014-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KISNER DANIEL L | Director | J Other | 2014-02-19 | 2016-12-30 | 3,145 | — | $0 | 3,145 | SEC↗ |
| Aberdare Partners III LP | Other | J Other | 2014-02-19 | 2014-02-25 | 36,634 | — | $0 | 0 | SEC↗ |
| Aberdare Partners III LP | Other | J Other | 2014-02-19 | 2014-02-25 | 36,634 | — | $0 | 36,634 | SEC↗ |
| Aberdare Partners III LP | Other | J Other | 2014-02-19 | 2014-02-25 | 30,216 | — | $0 | 22,203 | SEC↗ |
| Aberdare Partners III LP | Other | J Other | 2014-02-19 | 2014-02-25 | 1,283,589 | — | $0 | 943,355 | SEC↗ |
| KLINGENSTEIN PAUL H | Director | J Other | 2014-02-19 | 2014-02-25 | 36,634 | — | $0 | 36,634 | SEC↗ |
| KLINGENSTEIN PAUL H | Director | J Other | 2014-02-19 | 2014-02-25 | 30,216 | — | $0 | 22,203 | SEC↗ |
| KLINGENSTEIN PAUL H | Director | J Other | 2014-02-19 | 2014-02-25 | 1,283,589 | — | $0 | 943,355 | SEC↗ |
| KLINGENSTEIN PAUL H | Director | J Other | 2014-02-19 | 2014-02-25 | 20,322 | — | $0 | 20,322 | SEC↗ |
| KLINGENSTEIN PAUL H | Director | J Other | 2014-02-19 | 2014-02-25 | 8,731 | — | $0 | 8,731 | SEC↗ |
| KLINGENSTEIN PAUL H | Director | J Other | 2014-02-19 | 2014-02-25 | 36,634 | — | $0 | 0 | SEC↗ |
| KISNER DANIEL L | Director | J Other | 2014-02-19 | 2014-02-25 | 3,145 | — | $0 | 3,145 | SEC↗ |
| KISNER DANIEL L | Director | A Award deriv | 2014-02-07 | 2014-02-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Klassen Preston | Director | A Award deriv | 2014-02-07 | 2014-02-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BURGESS GARY C. | Sr. VP, Clin. Res. & CMO | A Award deriv | 2014-02-07 | 2014-02-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Cashion Charles | SVP, Finance, CFO and Sec. | A Award deriv | 2014-02-07 | 2014-02-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Mento Steven J | President, CEO & Director | A Award deriv | 2014-02-07 | 2014-02-11 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Spada Alfred P. | SVP, R&D and CSO | A Award deriv | 2014-02-07 | 2014-02-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HALE DAVID F | Director | M Exercise deriv | 2014-01-08 | 2014-01-10 | 12,121 | — | $0 | 0 | SEC↗ |
| HALE DAVID F | Director | M Exercise | 2014-01-08 | 2014-01-10 | 12,121 | $0.99 | $12.0K | 24,242 | SEC↗ |
| HALE DAVID F | Director | M Exercise deriv | 2013-09-26 | 2013-09-27 | 12,121 | — | $0 | 0 | SEC↗ |
| HALE DAVID F | Director | M Exercise | 2013-09-26 | 2013-09-27 | 12,121 | $2.31 | $28.0K | 12,121 | SEC↗ |
| MPM BioVentures IV LLC | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 8,333,334 | — | $0 | 0 | SEC↗ |
| MPM BioVentures IV LLC | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 265,837 | — | $0 | 0 | SEC↗ |
| MPM BioVentures IV LLC | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 32,220 | — | $0 | 32,220 | SEC↗ |
| Foley Todd | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 265,837 | — | $0 | 0 | SEC↗ |
| Foley Todd | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 32,220 | — | $0 | 32,220 | SEC↗ |
| Foley Todd | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 8,333,334 | — | $0 | 0 | SEC↗ |
| Scopa James Paul | Director | A Award deriv | 2013-07-30 | 2013-08-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Scopa James Paul | Director | C Conversion deriv | 2013-07-30 | 2013-08-01 | 32,220 | — | $0 | 32,220 | SEC↗ |
| Scopa James Paul | Director | C Conversion deriv | 2013-07-30 | 2013-08-01 | 265,837 | — | $0 | 0 | SEC↗ |
| Scopa James Paul | Director | C Conversion deriv | 2013-07-30 | 2013-08-01 | 8,333,334 | — | $0 | 0 | SEC↗ |
| ADVENT VENTURE PARTNERS LLP | 10% Owner | X Exercise deriv | 2013-07-30 | 2013-08-01 | 577,599 | — | $0 | 0 | SEC↗ |
| ADVENT VENTURE PARTNERS LLP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 5,576,786 | — | $0 | 0 | SEC↗ |
| ADVENT VENTURE PARTNERS LLP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 10,000,000 | — | $0 | 0 | SEC↗ |
| Cashion Charles | SVP, Finance, CFO and Sec. | C Conversion deriv | 2013-07-30 | 2013-08-01 | 355,352 | — | $0 | 0 | SEC↗ |
| COOPERATIVE GILDE HEALTHCARE I | 10% Owner | X Exercise deriv | 2013-07-30 | 2013-08-01 | 385,070 | — | $0 | 0 | SEC↗ |
| COOPERATIVE GILDE HEALTHCARE I | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 3,717,861 | — | $0 | 0 | SEC↗ |
| COOPERATIVE GILDE HEALTHCARE I | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 6,666,668 | — | $0 | 0 | SEC↗ |
| HALE DAVID F | Director | A Award deriv | 2013-07-30 | 2013-08-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HALE DAVID F | Director | C Conversion deriv | 2013-07-30 | 2013-08-01 | 162,356 | — | $0 | 0 | SEC↗ |
| LACASSE LOUIS P | Director | A Award deriv | 2013-07-30 | 2013-08-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| LACASSE LOUIS P | Director | C Conversion deriv | 2013-07-30 | 2013-08-01 | 5,555,556 | — | $0 | 0 | SEC↗ |
| Malik Shahzad | Director, 10% Owner | A Award deriv | 2013-07-30 | 2013-08-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Malik Shahzad | Director, 10% Owner | X Exercise deriv | 2013-07-30 | 2013-08-01 | 577,599 | — | $0 | 0 | SEC↗ |
| Malik Shahzad | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 5,576,786 | — | $0 | 0 | SEC↗ |
| Malik Shahzad | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 10,000,000 | — | $0 | 0 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 5,701 | — | $0 | 0 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 137,626 | — | $0 | 0 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 73,395 | — | $0 | 73,395 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | X Exercise deriv | 2013-07-30 | 2013-08-01 | 73,395 | — | $0 | 0 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 42,336 | — | $0 | 0 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 5,131 | — | $0 | 5,131 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 246,775 | — | $0 | 0 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 242,205 | — | $0 | 0 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 363,308 | — | $0 | 0 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 5,846,236 | — | $0 | 0 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 10,483,166 | — | $0 | 0 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | A Award deriv | 2013-07-30 | 2013-08-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 120 | — | $0 | 120 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 997 | — | $0 | 0 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | X Exercise deriv | 2013-07-30 | 2013-08-01 | 1,727 | — | $0 | 0 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 1,727 | — | $0 | 1,727 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 8,552 | — | $0 | 0 | SEC↗ |
| Mento Steven J | President, CEO & Director | C Conversion deriv | 2013-07-30 | 2013-08-01 | 786,417 | — | $0 | 0 | SEC↗ |
| Perret Marc Olivier | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 3,717,861 | — | $0 | 0 | SEC↗ |
| Perret Marc Olivier | Director, 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 6,666,668 | — | $0 | 0 | SEC↗ |
| Perret Marc Olivier | Director, 10% Owner | X Exercise deriv | 2013-07-30 | 2013-08-01 | 385,070 | — | $0 | 0 | SEC↗ |
| Perret Marc Olivier | Director, 10% Owner | A Award deriv | 2013-07-30 | 2013-08-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | X Exercise deriv | 2013-07-30 | 2013-08-01 | 1,727 | — | $0 | 0 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 1,727 | — | $0 | 1,727 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 8,552 | — | $0 | 0 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 997 | — | $0 | 0 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 120 | — | $0 | 120 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 10,483,166 | — | $0 | 0 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 5,701 | — | $0 | 0 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 137,626 | — | $0 | 0 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 246,775 | — | $0 | 0 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 5,131 | — | $0 | 5,131 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 42,336 | — | $0 | 0 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | X Exercise deriv | 2013-07-30 | 2013-08-01 | 73,395 | — | $0 | 0 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 73,395 | — | $0 | 73,395 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 242,205 | — | $0 | 0 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 363,308 | — | $0 | 0 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion deriv | 2013-07-30 | 2013-08-01 | 5,846,236 | — | $0 | 0 | SEC↗ |
| Spada Alfred P. | SVP, R&D and CSO | C Conversion deriv | 2013-07-30 | 2013-08-01 | 363,927 | — | $0 | 0 | SEC↗ |
| Van Wart Harold | Director | A Award deriv | 2013-07-30 | 2013-08-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MPM BioVentures IV LLC | 10% Owner | C Conversion | 2013-07-30 | 2013-08-01 | 1,010,099 | — | $0 | 1,010,099 | SEC↗ |
| MPM BioVentures IV LLC | 10% Owner | P Buy | 2013-07-30 | 2013-08-01 | 165,265 | $11.00 | $1.82M | 1,192,080 | SEC↗ |
| MPM BioVentures IV LLC | 10% Owner | J Other | 2013-07-30 | 2013-08-01 | 16,716 | $11.00 | $183.9K | 1,026,815 | SEC↗ |
| Foley Todd | 10% Owner | J Other | 2013-07-30 | 2013-08-01 | 16,716 | $11.00 | $183.9K | 1,026,815 | SEC↗ |
| Foley Todd | 10% Owner | P Buy | 2013-07-30 | 2013-08-01 | 165,265 | $11.00 | $1.82M | 1,192,080 | SEC↗ |
| Foley Todd | 10% Owner | C Conversion | 2013-07-30 | 2013-08-01 | 1,010,099 | — | $0 | 1,010,099 | SEC↗ |
| Scopa James Paul | Director | J Other | 2013-07-30 | 2013-08-01 | 16,716 | $11.00 | $183.9K | 1,026,815 | SEC↗ |
| Scopa James Paul | Director | P Buy | 2013-07-30 | 2013-08-01 | 165,265 | $11.00 | $1.82M | 1,192,080 | SEC↗ |
| Scopa James Paul | Director | C Conversion | 2013-07-30 | 2013-08-01 | 1,010,099 | — | $0 | 1,010,099 | SEC↗ |
| ADVENT VENTURE PARTNERS LLP | 10% Owner | S Sale | 2013-07-30 | 2013-08-01 | 535 | $11.00 | $5.9K | 1,957,559 | SEC↗ |
| ADVENT VENTURE PARTNERS LLP | 10% Owner | J Other | 2013-07-30 | 2013-08-01 | 19,223 | $11.00 | $211.5K | 1,976,782 | SEC↗ |
| ADVENT VENTURE PARTNERS LLP | 10% Owner | P Buy | 2013-07-30 | 2013-08-01 | 190,054 | $11.00 | $2.09M | 2,166,836 | SEC↗ |
| ADVENT VENTURE PARTNERS LLP | 10% Owner | X Exercise | 2013-07-30 | 2013-08-01 | 70,003 | $0.08 | $5.6K | 1,958,094 | SEC↗ |
| ADVENT VENTURE PARTNERS LLP | 10% Owner | C Conversion | 2013-07-30 | 2013-08-01 | 1,888,091 | — | $0 | 1,888,091 | SEC↗ |
| Cashion Charles | SVP, Finance, CFO and Sec. | C Conversion | 2013-07-30 | 2013-08-01 | 43,072 | — | $0 | 149,738 | SEC↗ |
| COOPERATIVE GILDE HEALTHCARE I | 10% Owner | S Sale | 2013-07-30 | 2013-08-01 | 352 | $11.00 | $3.9K | 1,305,053 | SEC↗ |
| COOPERATIVE GILDE HEALTHCARE I | 10% Owner | J Other | 2013-07-30 | 2013-08-01 | 16,742 | $11.00 | $184.2K | 1,321,795 | SEC↗ |
| COOPERATIVE GILDE HEALTHCARE I | 10% Owner | P Buy | 2013-07-30 | 2013-08-01 | 165,525 | $11.00 | $1.82M | 1,487,320 | SEC↗ |
| COOPERATIVE GILDE HEALTHCARE I | 10% Owner | X Exercise | 2013-07-30 | 2013-08-01 | 46,675 | — | $0 | 1,305,405 | SEC↗ |
| COOPERATIVE GILDE HEALTHCARE I | 10% Owner | C Conversion | 2013-07-30 | 2013-08-01 | 1,258,730 | — | $0 | 1,258,730 | SEC↗ |
| HALE DAVID F | Director | J Other | 2013-07-30 | 2013-08-01 | 261 | $11.00 | $2.9K | 141,151 | SEC↗ |
| HALE DAVID F | Director | P Buy | 2013-07-30 | 2013-08-01 | 2,588 | $11.00 | $28.5K | 143,739 | SEC↗ |
| HALE DAVID F | Director | C Conversion | 2013-07-30 | 2013-08-01 | 19,679 | — | $0 | 140,890 | SEC↗ |
| LACASSE LOUIS P | Director | J Other | 2013-07-30 | 2013-08-01 | 12,537 | $11.00 | $137.9K | 685,937 | SEC↗ |
| LACASSE LOUIS P | Director | P Buy | 2013-07-30 | 2013-08-01 | 123,950 | $11.00 | $1.36M | 809,887 | SEC↗ |
| LACASSE LOUIS P | Director | C Conversion | 2013-07-30 | 2013-08-01 | 673,400 | — | $0 | 673,400 | SEC↗ |
| Malik Shahzad | Director, 10% Owner | S Sale | 2013-07-30 | 2013-08-01 | 535 | $11.00 | $5.9K | 1,957,559 | SEC↗ |
| Malik Shahzad | Director, 10% Owner | J Other | 2013-07-30 | 2013-08-01 | 19,223 | $11.00 | $211.5K | 1,976,782 | SEC↗ |
| Malik Shahzad | Director, 10% Owner | P Buy | 2013-07-30 | 2013-08-01 | 190,054 | $11.00 | $2.09M | 2,166,836 | SEC↗ |
| Malik Shahzad | Director, 10% Owner | X Exercise | 2013-07-30 | 2013-08-01 | 70,003 | $0.08 | $5.6K | 1,958,094 | SEC↗ |
| Malik Shahzad | Director, 10% Owner | C Conversion | 2013-07-30 | 2013-08-01 | 1,888,091 | — | $0 | 1,888,091 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | S Sale | 2013-07-30 | 2013-08-01 | 14 | $11.00 | $154 | 49,698 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | X Exercise | 2013-07-30 | 2013-08-01 | 1,727 | $0.08 | $138 | 49,712 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion | 2013-07-30 | 2013-08-01 | 46,594 | — | $0 | 47,985 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | J Other | 2013-07-30 | 2013-08-01 | 251 | $11.00 | $2.8K | 49,949 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | P Buy | 2013-07-30 | 2013-08-01 | 2,470 | $11.00 | $27.2K | 52,419 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | P Buy | 2013-07-30 | 2013-08-01 | 104,952 | $11.00 | $1.15M | 2,226,944 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | C Conversion | 2013-07-30 | 2013-08-01 | 1,979,321 | — | $0 | 2,038,535 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | X Exercise | 2013-07-30 | 2013-08-01 | 73,395 | $0.08 | $5.9K | 2,111,930 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | S Sale | 2013-07-30 | 2013-08-01 | 552 | $11.00 | $6.1K | 2,111,378 | SEC↗ |
| KLINGENSTEIN PAUL H | Director, 10% Owner | J Other | 2013-07-30 | 2013-08-01 | 10,614 | $11.00 | $116.8K | 2,121,992 | SEC↗ |
| Mento Steven J | President, CEO & Director | J Other | 2013-07-30 | 2013-08-01 | 1,395 | $11.00 | $15.3K | 371,869 | SEC↗ |
| Mento Steven J | President, CEO & Director | P Buy | 2013-07-30 | 2013-08-01 | 13,800 | $11.00 | $151.8K | 385,669 | SEC↗ |
| Mento Steven J | President, CEO & Director | C Conversion | 2013-07-30 | 2013-08-01 | 95,323 | — | $0 | 370,474 | SEC↗ |
| Perret Marc Olivier | Director, 10% Owner | C Conversion | 2013-07-30 | 2013-08-01 | 1,258,730 | — | $0 | 1,258,730 | SEC↗ |
| Perret Marc Olivier | Director, 10% Owner | X Exercise | 2013-07-30 | 2013-08-01 | 46,675 | — | $0 | 1,305,405 | SEC↗ |
| Perret Marc Olivier | Director, 10% Owner | S Sale | 2013-07-30 | 2013-08-01 | 352 | $11.00 | $3.9K | 1,305,053 | SEC↗ |
| Perret Marc Olivier | Director, 10% Owner | J Other | 2013-07-30 | 2013-08-01 | 16,742 | $11.00 | $184.2K | 1,321,795 | SEC↗ |
| Perret Marc Olivier | Director, 10% Owner | P Buy | 2013-07-30 | 2013-08-01 | 165,525 | $11.00 | $1.82M | 1,487,320 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | X Exercise | 2013-07-30 | 2013-08-01 | 1,727 | $0.08 | $138 | 49,712 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion | 2013-07-30 | 2013-08-01 | 46,594 | — | $0 | 47,985 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | X Exercise | 2013-07-30 | 2013-08-01 | 73,395 | $0.08 | $5.9K | 2,111,930 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | J Other | 2013-07-30 | 2013-08-01 | 10,614 | $11.00 | $116.8K | 2,121,992 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | S Sale | 2013-07-30 | 2013-08-01 | 552 | $11.00 | $6.1K | 2,111,378 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | S Sale | 2013-07-30 | 2013-08-01 | 14 | $11.00 | $154 | 49,698 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | J Other | 2013-07-30 | 2013-08-01 | 251 | $11.00 | $2.8K | 49,949 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | P Buy | 2013-07-30 | 2013-08-01 | 2,470 | $11.00 | $27.2K | 52,419 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | C Conversion | 2013-07-30 | 2013-08-01 | 1,979,321 | — | $0 | 2,038,535 | SEC↗ |
| Aberdare Ventures III LP | 10% Owner | P Buy | 2013-07-30 | 2013-08-01 | 104,952 | $11.00 | $1.15M | 2,226,944 | SEC↗ |
| Spada Alfred P. | SVP, R&D and CSO | C Conversion | 2013-07-30 | 2013-08-01 | 44,112 | — | $0 | 235,021 | SEC↗ |